CXCL10 and dermatomyositis: To validate the biomarker potential of galectin‐9 and CXCL10, we measured the proteins in blood samples from patients with juvenile DM from 2 independent validation cohorts: an external validation cohort (EVC) from London and an internal validation cohort (IVC) from Utrecht.